Literature DB >> 16741156

Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII.

Erik N T P Bakker1, Adrian Pistea, Jos A E Spaan, Titia Rolf, Carlie J de Vries, Nico van Rooijen, Eleonara Candi, Ed VanBavel.   

Abstract

Chronic changes in blood flow induce an adaptation of vascular caliber. Thus, arteries show inward remodeling after a reduction in blood flow. We hypothesized that this remodeling depends on the crosslinking enzyme tissue-type transglutaminase (tTG). Flow-dependent remodeling was studied in wild-type (WT) and tTG-null mice using a surgically imposed change in blood flow in small mesenteric arteries. WT mice showed inward remodeling after 2 days of low blood flow, which was absent in arteries from tTG-null mice. Yet, after continued low blood flow for 7 days, inward remodeling was similar in arteries from WT and tTG-null mice. Studying the alternative pathways of remodeling, we identified a relatively high expression of the plasma transglutaminase factor XIII in arteries of WT and tTG-null mice. In addition, vessels from both WT and tTG-null mice showed the presence of transglutaminase-specific crosslinks. An accumulation of adventitial monocytes/macrophages was found in vessels exposed to low blood flow in tTG-null mice. Because monocytes/macrophages may represent a source of factor XIII, tTG-null mice were treated with liposome-encapsulated clodronate. Elimination of monocytes/macrophages with liposome-encapsulated clodronate reduced both the expression of factor XIII and inward remodeling in tTG-null mice. In conclusion, tTG plays an important role in the inward remodeling of small arteries associated with decreased blood flow. Adventitial monocytes/macrophages are a source of factor XIII in tTG-null mice and contribute to an alternative, delayed mechanism of inward remodeling when tTG is absent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741156     DOI: 10.1161/01.RES.0000229657.83816.a7

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  44 in total

1.  Recombinant factor XIII mitigates hemorrhagic shock-induced organ dysfunction.

Authors:  Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Inga V Malinina; Edwin A Deitch; Eva H Olsen
Journal:  J Surg Res       Date:  2010-12-31       Impact factor: 2.192

2.  Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.

Authors:  Kyle B Johnson; Humphrey Petersen-Jones; Janice M Thompson; Kiyotaka Hitomi; Miho Itoh; Erik N T P Bakker; Gail V W Johnson; Gozde Colak; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

Review 3.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

Review 4.  Monocytes and macrophages in abdominal aortic aneurysm.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2017-04-13       Impact factor: 32.419

Review 5.  Small artery remodelling in hypertension: causes, consequences and therapeutic implications.

Authors:  Michael J Mulvany
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

6.  Bypass to the left coronary artery system may accelerate left main coronary artery negative remodeling and calcification.

Authors:  Yunpeng Shang; Gary S Mintz; Jun Pu; Jun Guo; Nobuaki Kobayashi; Theresa Franklin-Bond; Martin B Leon; Jeffrey W Moses; Akiko Maehara; Takehisa Shimizu; Tadayuki Yakushiji
Journal:  Clin Res Cardiol       Date:  2013-07-27       Impact factor: 5.460

Review 7.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target.

Authors:  Reza Aghamohammadzadeh; Sarah Withers; Fiona Lynch; Adam Greenstein; R Malik; Anthony Heagerty
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling?

Authors:  Madhu Gupta; Charles S Greenberg; Delrae M Eckman; David C Sane
Journal:  J Vasc Res       Date:  2007-05-03       Impact factor: 1.934

9.  Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.

Authors:  Kristen A Johnson; Monika Polewski; Robert A Terkeltaub
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

10.  MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries.

Authors:  Paul C Y Tang; Lingfeng Qin; Jacek Zielonka; Jing Zhou; Catherine Matte-Martone; Sonia Bergaya; Nico van Rooijen; Warren D Shlomchik; Wang Min; William C Sessa; Jordan S Pober; George Tellides
Journal:  J Exp Med       Date:  2008-12-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.